End-of-day quote
Korea S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
6,840
KRW
|
+1.48%
|
|
+1.18%
|
+1.63%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
62,767
|
55,905
|
70,852
|
68,033
|
50,743
|
62,243
|
Enterprise Value (EV)
1 |
6,663
|
-20,487
|
-11,374
|
-2,545
|
-16,852
|
-222.9
|
P/E ratio
|
8.96
x
|
7.08
x
|
10.6
x
|
6.41
x
|
4.04
x
|
1.69
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.96
x
|
2.14
x
|
2.7
x
|
2.2
x
|
1.57
x
|
3.05
x
|
EV / Revenue
|
0.21
x
|
-0.78
x
|
-0.43
x
|
-0.08
x
|
-0.52
x
|
-0.01
x
|
EV / EBITDA
|
0.8
x
|
-6.85
x
|
-2.13
x
|
-0.34
x
|
-2.25
x
|
0.1
x
|
EV / FCF
|
1.05
x
|
-9.83
x
|
-2.91
x
|
2.29
x
|
-11.8
x
|
-0.01
x
|
FCF Yield
|
95.5%
|
-10.2%
|
-34.3%
|
43.6%
|
-8.5%
|
-6,917%
|
Price to Book
|
0.48
x
|
0.38
x
|
0.47
x
|
0.42
x
|
0.29
x
|
0.3
x
|
Nbr of stocks (in thousands)
|
9,963
|
9,606
|
9,397
|
9,397
|
9,397
|
9,249
|
Reference price
2 |
6,300
|
5,820
|
7,540
|
7,240
|
5,400
|
6,730
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/15/21
|
3/15/22
|
3/14/23
|
3/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
32,102
|
26,160
|
26,252
|
30,867
|
32,403
|
20,387
|
EBITDA
1 |
8,353
|
2,993
|
5,345
|
7,593
|
7,495
|
-2,146
|
EBIT
1 |
7,257
|
2,018
|
4,315
|
6,664
|
6,606
|
-2,678
|
Operating Margin
|
22.61%
|
7.71%
|
16.44%
|
21.59%
|
20.39%
|
-13.13%
|
Earnings before Tax (EBT)
1 |
9,611
|
9,753
|
7,661
|
14,091
|
10,763
|
21,214
|
Net income
1 |
6,996
|
7,992
|
6,684
|
10,615
|
12,563
|
37,261
|
Net margin
|
21.79%
|
30.55%
|
25.46%
|
34.39%
|
38.77%
|
182.77%
|
EPS
2 |
702.9
|
821.5
|
709.4
|
1,130
|
1,337
|
3,989
|
Free Cash Flow
1 |
6,361
|
2,083
|
3,904
|
-1,110
|
1,433
|
15,418
|
FCF margin
|
19.82%
|
7.96%
|
14.87%
|
-3.6%
|
4.42%
|
75.63%
|
FCF Conversion (EBITDA)
|
76.15%
|
69.61%
|
73.03%
|
-
|
19.12%
|
-
|
FCF Conversion (Net income)
|
90.92%
|
26.07%
|
58.4%
|
-
|
11.41%
|
41.38%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/15/21
|
3/15/22
|
3/14/23
|
3/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
56,104
|
76,391
|
82,226
|
70,579
|
67,595
|
62,466
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
6,361
|
2,083
|
3,904
|
-1,110
|
1,433
|
15,418
|
ROE (net income / shareholders' equity)
|
5.7%
|
5.52%
|
4.1%
|
6.85%
|
7.27%
|
7.48%
|
ROA (Net income/ Total Assets)
|
3.32%
|
0.79%
|
1.51%
|
2.21%
|
2.07%
|
-0.77%
|
Assets
1 |
210,461
|
1,007,636
|
441,248
|
479,702
|
607,688
|
-4,827,842
|
Book Value Per Share
2 |
13,196
|
15,349
|
16,190
|
17,280
|
18,518
|
22,636
|
Cash Flow per Share
2 |
1,294
|
1,224
|
1,831
|
1,913
|
2,159
|
2,179
|
Capex
1 |
281
|
858
|
282
|
2,385
|
517
|
465
|
Capex / Sales
|
0.88%
|
3.28%
|
1.08%
|
7.73%
|
1.6%
|
2.28%
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/15/21
|
3/15/22
|
3/14/23
|
3/18/24
|
|
1st Jan change
|
Capi.
|
---|
| +1.63% | 45.24M | | -22.22% | 1.55B | | +171.03% | 161M | | +17.51% | 120M | | +22.54% | 80.39M |
Biometric Products
|